Department of Chemical and Biological Engineering
Keith B. Neeves has not added Biography.
If you are Keith B. Neeves and would like to personalize this page please email our Author Liaison for assistance.
Model neural prostheses with integrated microfluidics: a potential intervention strategy for controlling reactive cell and tissue responses.
IEEE transactions on bio-medical engineering Nov, 2004 | Pubmed ID: 15536908
Flexible multielectrodes can resolve multiple muscles in an insect appendage.
Journal of neuroscience methods Jan, 2007 | Pubmed ID: 16899299
Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.
Brain research Nov, 2007 | Pubmed ID: 17920047
Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow.
Blood Apr, 2008 | Pubmed ID: 18203955
A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood.
Lab on a chip May, 2008 | Pubmed ID: 18432339
Flexible microfluidic devices supported by biodegradable insertion scaffolds for convection-enhanced neural drug delivery.
Biomedical microdevices Aug, 2009 | Pubmed ID: 19353271
Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology Jul, 2009 | Pubmed ID: 19390055
Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2009 | Pubmed ID: 19940238
Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D.
Blood Dec, 2010 | Pubmed ID: 20855865
Microfluidic probes in the treatment of brain-related diseases.
Drug news & perspectives Oct, 2010 | Pubmed ID: 21031165
Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion.
Langmuir : the ACS journal of surfaces and colloids Nov, 2011 | Pubmed ID: 21967679
Interaction and localization of synthetic nanoparticles in healthy and cystic fibrosis airway epithelial cells: effect of ozone exposure.
Journal of aerosol medicine and pulmonary drug delivery Feb, 2012 | Pubmed ID: 22007674
Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex.
Annals of biomedical engineering Feb, 2012 | Pubmed ID: 22009318
Single- and two-phase flow in microfluidic porous media analogs based on Voronoi tessellation.
Lab on a chip Jan, 2012 | Pubmed ID: 22094719
Catch me if you can: isolating circulating tumor cells from flowing blood.
Clinical chemistry May, 2012 | Pubmed ID: 22353214
High content evaluation of shear dependent platelet function in a microfluidic flow assay.
Annals of biomedical engineering Feb, 2013 | Pubmed ID: 23001359
Tissue Factor Signals Airway Epithelial Basal Cell Survival via Coagulation and PAR1/2.
American journal of respiratory cell and molecular biology Oct, 2012 | Pubmed ID: 23065128
Collagen-induced thrombosis in large vessels using native prothrombotic substrates.
Thrombosis research Jan, 2013 | Pubmed ID: 23174625
Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays.
PloS one , 2013 | Pubmed ID: 23355889
Optic imaging of single and two-phase pressure-driven flows in nano-scale channels.
Lab on a chip Mar, 2013 | Pubmed ID: 23370894
Measuring cell mechanics by optical alignment compression cytometry.
Lab on a chip Apr, 2013 | Pubmed ID: 23440063
The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury.
Current opinion in hematology Sep, 2013 | Pubmed ID: 23872531
The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models.
PloS one , 2013 | Pubmed ID: 24236042
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유